News About: Pharm. Industry
MSD Korea makes first shipment to Dongwon Pharma
MSD Korea MSD embarked on its first dealing with Dongwon Pharma Group by making its first drug shipment to to the wholesaler on October 19.
Market insiders said other multinational firms will follow suit sooner or ...
Premature ejaculation pill goes on sale
Janssen Korea said it has launched Priligy (dapoxetine), a premature ejaculation (PE) pill, from October 20 and received a great number of phone calls from the local customers earlier.
Dapoxetine is a unique, short...
Kwangdong, most favored Korean company
Kwangdong Pharm ranked as the most popular Korean company among the students attending at 200 universities nationwide, a local poll showed.
According to a survey by the University News Network (www.unn.net), an onl...
Boryung opens Beijing office
Boryung Group has opened an office in Beijing, becoming a foreign base to advance into other countries.
Under the localized marketing strategy, its business includes expanded sales of a leading antacid “Gelfos” in ...
Lawmakers visit Yuhan Research Institute
A group of lawmakers who belong to the National Assembly's Health and Welfare Committee visited on October 16 Yuhan Corporation’s cutting-edge research center e located at Giheung, Yongin City of Kyunggi Province, as ...
KPMA suggests hike in health insurance premiums
The Korea Pharmaceutical Manufactures Association (KPMA) recommended an increase in the contribution rate in Korea's national health insurance plan in a press interview on October 15.
Uh Joon-sun, chairman of KPMA...
Dong-A expands in painkiller market
Boosted by robust sales of a new isopropylantipyrine (IPA)-free painkiller “Amcilon Q”, Dong-A Pharm is attempting to become a leading player in the domestic analgesic market, which has been dominated by Samjin’ Gewor...
Wholesalers give some multinationals ultimatum
Some multinational firms, who promised to expand direct transaction with domestic wholesalers, have met a major hurdle with the Korea Association of Pharmaceutical Wholesaler issuing “expansion of direct transaction w...
Chong Kun Dang shows continuous sales growth for 6 consecutive months
Chong Kun Dang Pharmaceutical has witnessed ceaseless sales growth rates for six consecutive months due to robust sales of its Cozaar generic, according to data released by market analysts.
The domestic ethical ma...
Local biopharmaceutical firm to conduct phase 3 trial for Enbrel
Biotrion Co., an affiliated biopharmaceutical company of Futureinfonet in Korea, says it has received approval from the Korea Food and Drug Administration to conduct phase 3 clinical trial covering its biosimilar drug...
